MedPath

A STUDY HELD TO SEE THE EFFECT OF NIMBADI BIDALAKA IN THE MANAGEMENT OF KRIMIGRANTHI (BLEPHARITIS)

Phase 2/3
Recruiting
Conditions
Blepharitis. Ayurveda Condition: KRUMIGRANTHIH,
Registration Number
CTRI/2023/03/050424
Lead Sponsor
Kirti Kailasrao Sengaonkar
Brief Summary

The aim of the study is to see the efficacy of Nimbadi Bidalaka in reducing and management of the inflammation caused in Krimigranthi (Blepharitis).

The study will be completed with 31 patients showing sign and symptoms of Krimigranthi (Blepharitis).

The paste of medicine is applied over closed eyes of patient in circular form except on lid margin and eyelashes in the prescribed quantity for a duration of 5 days and assessment will be done 0th and 6th day.

The  Conclusion would be drawn on the basis of statistical analysis and result would be interpreted accordingly

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
31
Inclusion Criteria

1 The Patients presenting sign and symptoms of Krimigranthi with Itching of eyelids Burning sensation Lacrimation and white scales along the base of eyelashes 2 Between the age group 18 to 60 years.

Exclusion Criteria

1 Blepharitis associated with conjunctivitis and Ulcerative Blepharitis 2 Patients suffering from Ptosis Psoriasis Drug induced Blepharitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Nimbadi Bidalaka is effective in the management of Krimigranthi (Blepharitis).5 days with 2 follow up (0th day and 6th day)
Secondary Outcome Measures
NameTimeMethod
There is significant effect of Nimbadi Bidalaka on Krimigranthi (Blepharitis )5 days with 2 follow ups (0th day and 6th day)

Trial Locations

Locations (1)

Dr D Y Patil College of Ayurved and Research Centre Pimpri Pune

🇮🇳

Pune, MAHARASHTRA, India

Dr D Y Patil College of Ayurved and Research Centre Pimpri Pune
🇮🇳Pune, MAHARASHTRA, India
Kirti Kailasrao Sengaonkar
Principal investigator
8208921767
sengaonkarkirti07@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.